Dichloromethane → HCID 67516105, compound
Reaction equation
[N:1]([CH:4]1[CH2:13][CH2:12][C:11]2[CH:10]=[C:9]([C:14]3[N:18]=[C:17]([C:19]4[O:23][N:22]=[C:21]([C:24]5[CH:29]=[CH:28][CH:27]=[CH:26][CH:25]=5)[C:20]=4[C:30]([F:33])([F:32])[F:31])[O:16][N:15]=3)[CH:8]=[CH:7][C:6]=2[CH:5]1[O:34][Si:35]([C:38]([CH3:41])([CH3:40])[CH3:39])([CH3:37])[CH3:36])=[N+]=[N-].C(OCC)(=O)C.C(Cl)Cl.O.O.[Sn](Cl)Cl>CO>[Si:35]([O:34][CH:5]1[C:6]2[C:11](=[CH:10][C:9]([C:14]3[N:18]=[C:17]([C:19]4[O:23][N:22]=[C:21]([C:24]5[CH:25]=[CH:26][CH:27]=[CH:28][CH:29]=5)[C:20]=4[C:30]([F:31])([F:32])[F:33])[O:16][N:15]=3)=[CH:8][CH:7]=2)[CH2:12][CH2:13][CH:4]1[NH2:1])([C:38]([CH3:40])([CH3:41])[CH3:39])([CH3:36])[CH3:37]Participants
Reactant 4
Product 1
Reagents, catalysts & solvents 1
Procedure
Racemic 3-(6-azido-5-(tert-butyldimethylsilyloxy)-5,6,7,8-tetrahydronaphthalen-2-yl)-5-(3-phenyl-4-(trifluoromethyl)isoxazol-5-yl)-1,2,4-oxadiazole (500 mg, 0.86 mmol) was dissolved in MeOH (2131 μL), ethyl acetate (2131 μL), and CH2Cl2 (2131 μL). To this solution was added tin(II) chloride dihydrate (1.94 mg, 8.6 mmol) and the reaction mixture was stirred overnight. The solvent was evaporated and the residue was redissolved in CH2Cl2 and washed with 1N NaOH and brine. The organic phase was dried over MgSO4 and concentrated to afford racemic (1S*,2R*)-1-(tert-butyldimethylsilyloxy)-6-(5-(3-phenyl-4-(trifluoromethyl)isoxazol-5-yl)-1,2,4-oxadiazol-3-yl)-1,2,3,4-tetrahydronaphthalen-2-amine (46.2 mg, 0.83 mmol, 96.5%) as a pale yellow oil: LCMS=557.44 [M+H]+.
Workup
- customThe solvent was evaporated
- dissolutionthe residue was redissolved in CH2Cl2
- washwashed with 1N NaOH and brine
- dry with materialThe organic phase was dried over MgSO4
- concentrationconcentrated
Sources & evidence
- ORD record
- ord-55ac591fb9324b9baacccc0900a65a81
- Source dataset
- uspto-grants-2014_01
- Patent number
- US08629282B2
Reaction notes
Loading…